Fundz

Lonza to acquire Merck's CDMO unit for €-mid-triple

RECENTLY ACQUIREDNov 03, 2026

Acquiring Company

Lonza

Acquired Company

Merck KGaA CDMO business

BaselGermanyManufacturingBiotechnologyPharmaceuticalpharmaceuticalsManufacturingBiotechnology

Description

Merck KGaA is selling its contract development and manufacturing organisation business to Lonza for a mid-triple-digit million-euro amount. The deal includes five US facilities and about 1,100 employees, and it excludes the BioReliance testing business. The transaction is expected to close in the middle of 2027 and will be paid for in cash.

Who to call at Lonza, and when

When Lonza changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Lonza raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lonza, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lonza. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lonza

Location

Basel, Basel City, Switzerland

About

Lonza is a Swiss contract development and manufacturing organization (CDMO) with a focus on pharmaceutical development and manufacturing. The company is known for its scientific, technological, and market expertise, enabling it to be a partner of choice for the global biopharma industry.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lonza makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Wolfgang
Likely contact at this company
••••••••@••••••••

See Wolfgang's verified email →

Mary
Senior decision-maker at this company
••••••••@••••••••

See Mary's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Lonza's next move

Learn about Strategic plan

Frequently asked

Who acquired Merck KGaA CDMO business?

Merck KGaA CDMO business was acquired by Lonza, based in Basel. The deal was reported on November 3, 2026. Lonza is a Swiss contract development and manufacturing organization (CDMO) with a focus on pharmaceutical development and manufacturing. Lonza is privately held and operates in Manufacturing.

When did Lonza acquire Merck KGaA CDMO business?

Lonza's acquisition of Merck KGaA CDMO business was reported on November 3, 2026. Merck KGaA is selling its contract development and manufacturing organisation business to Lonza for a mid-triple-digit million-euro amount. The deal includes five US facilities and about 1,100 employees, and it excludes the BioReliance testing business. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Merck KGaA CDMO business do?

The CDMO business is the contract development and manufacturing unit of Merck KGaA, a German group. It includes five US facilities in California, Wisconsin, Missouri and Indiana and about 1,100 employees serving biopharma companies. It is privately held, operating in Manufacturing, and is based in Germany.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.